AN XRF STUDY OF TRACE-ELEMENTS ACCUMULATION IN KIDNEYS OF TUMOR-BEARING MICE AFTER TREATMENT WITH CIS-DDP WITH AND WITHOUT SELENITE AND SELENOCISTAMINE

被引:13
作者
SHENBERG, C
BOAZI, M
COHEN, J
KLEIN, A
KOJLER, M
NYSKA, A
机构
[1] BAR ILAN UNIV,DEPT LIFE SCI,RAMAT GAN,ISRAEL
[2] KIMRON VET INST,BET DAGAN,ISRAEL
关键词
TRACE ELEMENTS; XRF; MOUSE KIDNEY; CIS-DDP; SELENITE; SELENOCISTAMINE;
D O I
10.1007/BF02950787
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effect of cis-DDP treatment with and without selenite and selenocistamine was studied on kidneys of tumor-bearing mice. The amounts of cis-DDP, selenite, and selenocistamine injected were chosen so as to be compatible with the treatment of humans. The animals were sacrificed at 7, 14, and 28 d after treatment. The kidneys were removed and subjected to trace element analysis by a novel X-ray fluorescence (XRF) method and for pathological assessment. The results show that following treatment with cis-DDP, K, Fe, Cu, and Zn reach a maximum level after 7 d; K, Fe, and Cu levels were significantly reduced by the addition of selenite. The level of Zn was reduced only in groups treated with selenite whereas that of K and Cu was reduced also in groups treated with selenocistamine with and without cis-DDP. The greatest increase in Pt and Se levels was reached 1 wk after injection with cis-DDP, with and without seleno-compounds, and in the case of Pt was partly reduced by addition of selenite. Se returned to control values 2 wk after injection, although Pt was still high in all groups 2 and 4 wk after injection. The results corroborate the findings of our previous studies. The effect of selenocistamine in cis-DDP treated mice was partly insufficient. The pathological examination of the kidneys did not show any differences in the effect of various additives during the study.
引用
收藏
页码:137 / 149
页数:13
相关论文
共 14 条
[1]  
ARAYA Y, 1990, Hokkaido Journal of Medical Science, V65, P245
[2]  
BALDEW GS, 1990, CANCER RES, V50, P731
[3]  
BARNARD CFJ, 1986, CHEM BRIT, V22, P1001
[4]  
BERRY JP, 1988, J SUBMICR CYTOL PATH, V20, P59
[5]  
BERRY JP, 1984, CANCER RES, V44, P2864
[6]  
CARVAJAL SG, 1989, J MED CHEM, V32, P2063
[7]  
GERAN RI, 1972, CANCER CHEMOTHER R 3, V3, P7
[8]  
GUIDI GC, 1990, J TRACE ELEM ELECT H, V4, P157
[9]  
HAY R, 1992, AM TYPE COLLECTION C
[10]   THE EFFECTS OF CO-ADMINISTRATION OF SELENIUM AND CISPLATIN (CDDP) ON CDDP-INDUCED TOXICITY AND ANTITUMOUR ACTIVITY [J].
OHKAWA, K ;
TSUKADA, Y ;
DOHZONO, H ;
KOIKE, K ;
TERASHIMA, Y .
BRITISH JOURNAL OF CANCER, 1988, 58 (01) :38-41